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Abstract. 
 
Caveolins are integral membrane proteins 
which are a major component of caveolae. In addition, 
caveolins have been proposed to cycle between intra-
cellular compartments and the cell surface but the exact 
trafﬁcking route and targeting information in the cave-
olin molecule have not been deﬁned. We show that an-
tibodies against the caveolin scaffolding domain or 
against the COOH terminus of caveolin-1 show a strik-
ing speciﬁcity for the Golgi pool of caveolin and do not 
recognize surface caveolin by immunoﬂuorescence. To 
analyze the Golgi targeting of caveolin in more detail, 
caveolin mutants were expressed in ﬁbroblasts. Speciﬁc 
mutants lacking the NH
 
2
 
 terminus were targeted to the 
cis Golgi but were not detectable in surface caveolae. 
Moreover, a 32–amino acid segment of the putative 
COOH-terminal cytoplasmic domain of caveolin-3 was 
targeted speciﬁcally and exclusively to the Golgi com-
plex and could target a soluble heterologous protein, 
green ﬂuorescent protein, to this compartment. Palmi-
toylation-deﬁcient COOH-terminal mutants showed 
negligible association with the Golgi complex. This 
study deﬁnes unique Golgi targeting information in the 
caveolin molecule and identiﬁes the cis Golgi complex 
as an intermediate compartment on the caveolin cycling 
pathway.
Key words: caveolae • caveolin • Golgi complex • tar-
geting • palmitoylation
 
C
 
AVEOLAE
 
 are a characteristic plasma membrane
feature of many mammalian cell types. Since their
first visualization by the pioneers of electron mi-
croscopy (Palade, 1953; Yamada, 1955), caveolae have
been defined by their characteristic morphology appearing
as bulb-shaped uncoated invaginations of 55–80nm diame-
ter (Severs, 1988; Anderson, 1993, 1998; Parton, 1996). They
are the major surface feature of many highly differentiated
mammalian cells such as adipocytes, smooth muscle cells,
and endothelial cells. In the latter, caveolae have been
shown to bud from the surface and transport solutes across
the endothelial monolayer (Simionescu and Simionescu,
1991; Schnitzer et al., 1994). In fibroblasts caveolae have
been proposed to represent an alternative endocytic path-
way (Montesano et al., 1982; Tran et al., 1987; Parton et al.,
1994) and recent evidence suggests caveolae are vehicles
for the entry of certain viruses into animal cells (Anderson
et al., 1996; Stang et al., 1997; Parton and Lindsay, 1999).
A significant advance in the caveolae field came with
the cloning and characterization of caveolins (VIP21/cave-
olin-1, caveolin-2, and caveolin-3 [cav-1, -2, -3])
 
1
 
, major
membrane proteins of caveolae (Glenney and Soppet,
1992; Kurzchalia et al., 1992; Way and Parton, 1995;
Scherer et al., 1996; Tang et al., 1996). Caveolins are in-
tegral membrane components which form a hairpin in
 
the membrane with both NH
 
2
 
 and COOH termini oriented
towards the cytoplasm (Dupree et al., 1993; Monier et
al., 1995). Caveolins share a putative 33–amino acid in-
tramembrane domain flanked by charged residues. Recent
evidence suggests that caveolins are structural compo-
nents involved in caveolae formation (Parton, 1996),
key regulators of signaling events (Okamoto et al., 1998)
and involved in cholesterol transport and regulation (Fielding
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and Fielding, 1997). Expression of cav-1 in cells that lack
caveolae causes de novo formation of caveolae (Fra et al.,
1995b; Lipardi et al., 1998). This property may be depen-
dent on the self-association of caveolin to form oligomers
(Monier et al., 1995; Sargiacomo et al., 1995) and interac-
tion with both cholesterol (Murata et al., 1995) and gly-
cosphingolipids (Fra et al., 1995a) in detergent-insoluble
glycosphingolipid-enriched surface domains (DIGs; Par-
ton and Simons, 1995). We have also postulated that this
property has been exploited in the formation of other cell
surface domains such as the T-tubule system of muscle
cells (Parton et al., 1997).
Accumulating evidence in vitro and in vivo suggests a
key role for caveolins in signal transduction. Caveolins
show a functional interaction with the small GTP binding
protein ras (Song et al., 1996), src kinases (Li et al., 1996b),
trimeric G protein subunits (Li et al., 1995), and other sig-
naling molecules (reviewed by Okamoto et al., 1998). It
has been proposed that caveolin oligomers may form a
scaffold upon which signaling molecules are sequestered
on the cytoplasmic side of the plasma membrane. Despite
these advances, the relationship of the highly conserved
structure of caveolae to their role in signaling remains un-
clear and some cell types are apparently able to mediate sig-
naling events without invaginated caveolae or caveolins
(Fra et al., 1994; Gorodinsky and Harris, 1995).
The majority of the above studies have concentrated on
the plasma membrane role of caveolins, yet there is con-
siderable evidence for a functional role of caveolin in in-
tracellular compartments. In particular, caveolins have
been implicated in polarized vesicular traffic in epithelia
(Scheiffele et al., 1998) and in cholesterol transport (Smart
et al., 1994, 1996; Fielding and Fielding, 1997). Both of
these functions appear to rely on a dynamic cycling of ca-
veolin through the cell. Antibodies to the NH
 
2
 
 terminus of
cav-1 preferentially label surface caveolae (Dupree et al.,
1993) but antibodies against the COOH terminus of the
same protein show a staining pattern characteristic of the
Golgi complex (Dupree et al., 1993). This pattern was in-
terpreted as representing the TGN on the basis of colocal-
ization of caveolin with a viral protein accumulated in the
TGN at 20
 
8
 
C by confocal microscopy. These observations,
together with the identification of cav-1 within post TGN
vesicles (Kurzchalia et al., 1992), suggested that cav-1 con-
stantly cycles between the TGN and the cell surface (Du-
pree et al., 1993). Recent work showed that antibodies to
cav-1 specifically inhibit transport from the TGN to the
apical surface (Scheiffele et al., 1998). These results, to-
gether with studies showing a role for cholesterol in apical
transport (Keller and Simons, 1998), have led to a model in
which caveolin plays a role in the formation or stabiliza-
tion of lipid domains within the TGN (Simons and Ikonen,
1997). This model relies on rapid trafficking of caveolin
between the surface and the TGN. Other data provided
evidence for a less conventional cycling pathway for cav-1.
These studies showed that cav-1 redistributes to the lumen
of the ER in response to treatment with cholesterol oxi-
dase in a reversible manner (Smart et al., 1994). This cycle
appears to occur constitutively even without cholesterol
oxidase treatment and can be disrupted by treatment with
microtubule-depolymerizing agents when caveolin accu-
mulates within the endoplasmic reticulum/Golgi interme-
 
diate compartment (ERGIC; Conrad et al., 1995). This
pathway was proposed to play a role in cholesterol trans-
port; caveolin directly binds cholesterol (Murata et al.,
1995) and caveolin expression increases cholesterol trans-
port from the ER to the plasma membrane (Smart et al.,
1996) apparently via a cytosolic intermediate (Uitten-
bogaard et al., 1998). As cav-1 expression is regulated by
cholesterol (Fielding et al., 1997; Hailstones et al., 1998)
through cholesterol-responsive promoter elements (Bist et
al., 1997) this points to a primary role for caveolin in cho-
lesterol homeostasis.
In view of these apparently conflicting data, we have re-
assessed and further characterized the intracellular loca-
tion and routing of caveolin using immunofluorescence
and immunoelectron microscopy and a mutational ap-
proach. We show that antibodies to the COOH terminus
of cav-1 or to the scaffolding domain preferentially label
caveolin within the cis-Golgi and not the cell surface.
Golgi targeting information is located within the COOH
terminus of the caveolin molecule and this domain is suffi-
cient to target a soluble protein to the cytoplasmic face of
the Golgi apparatus.
 
Materials and Methods
 
Materials
 
Polyclonal antibodies were raised against a peptide corresponding to a
highly conserved region of cav-3, with a COOH-terminal cysteine for cou-
pling to the carrier (CGFEDVIAEPEGTYSFDE). Antibodies were affin-
ity purified as described previously (Parton et al., 1997). Other domain-
specific caveolin anti-peptide antibodies have been described previously
(Dupree et al., 1993). Anti-chick caveolin (anti-cavFL) was purchased
from Zymed Laboratories. Affinity-purified rabbit antibodies (unconju-
gated and biotinylated) against p23 (Rojo et al., 1997) were provided by
Dr. Manuel Rojo (University of Geneva, Switzerland). Antibodies against
the mammalian KDEL-receptor ERD2 (Griffiths et al., 1994) and giantin
(Linstedt and Hauri, 1993) were gifts of Dr. Hans-Peter Hauri (Biozen-
trum, Basel, Switzerland) and Dr. Hans-Dieter Soeling (Goettingen, Ger-
many). Fluorescein-labeled anti–mouse IgG, Cy3-labeled anti–rabbit IgG
and Cy2-labeled streptavidin were from Jackson ImmunoResearch. The
hybridoma used to generate monoclonal mouse anti-HA was provided by
Professor David James (University of Queensland). The rabbit anti-HA
and the cDNA for myc-tagged sialotransferase were both kindly provided
by Dr. Tommy Nilsson (EMBL, Heidelberg, Germany). Nocodazole was
purchased from Sigma Chemical Co. and was kept at 
 
2
 
20
 
8
 
C (stock solu-
tion 10 mM in DMSO).
 
Cell Culture
 
BHK cells were grown and maintained as described previously (Gruen-
berg et al., 1989). Primary human fibroblasts were a gift of Professor D.
James and were maintained in RPMI supplemented with 10% FCS.
C2C12 cells were cultured as described previously (Way and Parton,
1995).
 
Recombinant Semliki Forest Virus
 
Recombinant Semliki Forest Virus (SFV)-cav-1 and SFV-cav-3 were pre-
pared in BHK cells according to an established protocol (Liljestrom and
Garoff, 1991; Olkkonen et al., 1993). In brief, canine cav-1 and mouse
cav-3 were PCR amplified from the original clones with introduced 5
 
9
 
BamHI and 3
 
9
 
 SmaI restriction sites. After sequencing of both strands, the
cDNAs were cloned into the appropriate sites of pSFV1 (Gibco, Grand
Island, NY). RNA was generated by in vitro
 
 
 
transcription from pSFV-
cav-1, pSFV-cav-3, and pSFV-Helper1 and electroporated into BHK cells.
Culture supernatant was harvested after 48 h and frozen at 
 
2
 
70
 
8
 
C. The
BHK cells used to produce recombinant SFV were harvested and pre-
pared for Western blotting. The expression level of cav-1 was 
 
.
 
10-fold
higher than endogenous levels. 
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For immunofluorescence experiments cells were infected with undi-
luted recombinant SFV containing culture supernatant for 1 h at 37
 
8
 
C af-
ter which the infection medium was diluted 10-fold with normal culture
medium and incubated for a further 12 h. The cav-2-SFV construct was
kindly provided by Dr. Elina Ikonen (National Public Health Institute,
Helsinki, Finland).
 
Subcellular Fractionation
 
BHK cell fractions were kindly provided by Professor Jean Gruenberg.
BHK cells were homogenized in isotonic sucrose solution and the mem-
branes of the post-nuclear supernatant were fractionated using a step su-
crose gradient to produce a fraction enriched in p23 and ERD2 exactly as
described (Rojo et al., 1997).
 
Cloning and Expression
 
A series of NH
 
2
 
-terminal truncation mutants of cav-3 were generated
from the original cDNA clone by PCR. Cav3
 
DIH
 
 (residues 16-151),
Cav3
 
NED
 
 (residues 33–151), Cav3
 
DGV
 
 (residues 54–151), and Cav3
 
KSY
 
(residues 108–151) were generated using the forward primers DIHfor 5
 
9
 
CGGGGTACCACCATGGACATTCACTGCAAGGAG 3
 
9
 
, NEDfor
5
 
9 
 
CGGGGTACCATGAATGAGGACATTGTGAAG 3
 
9
 
, DGVfor 5
 
9
 
CGGGGTACCACCATGGACGGTGTATGGAAGGTG 3
 
9
 
 and KSY-
for 5
 
9
 
 CGGGGTACCACCATGAAGAGCTACCTGATCGAG 3
 
9
 
, re-
spectively, and the reverse primer RORrev 5
 
9 
 
CCGGAATTCTTAGC-
CTTCCCTTCGCAGCACCACCTT 3
 
9
 
. Similarly, truncations of cav-1
(residues 135–183) were generated with and without three putative
COOH-terminal palmitoylation site cysteines mutated to alanine. Wild-
type (WT) cav-1 cDNA template was used to generate Cav1
 
KSF
 
 and cav-1
(Cys-Ala) cDNA template was used to generate Cav1
 
KSF
 
D
 
p both using
the forward primer CAV1(KSF)for 5
 
9 
 
CGGGGTACCACCATGAA-
GAGTTTCCTGATTGAGATTCAGTGC 3
 
9
 
 and the reverse primer
CAV1HArev 5
 
9
 
 ATAAGAATGCGGCCGCCTGTTTCTTTCTGCAT-
GTTGATGCGG 3
 
9
 
. The resulting mutants were cloned into pCB6-
KXHA (Way and Parton, 1995), a derivative of the eukaryotic expression
vector pCB6, containing the HA epitope tag (YPYDVPDYA), down-
stream of an in frame NotI site.
The Cav3
 
KSY
 
 region was also amplified with the forward primer,
KSYGFPfor 5
 
9
 
 CCGGAATTCGAAGAGCTACCTGATCGAG 3
 
9
 
, and
the reverse primer, CAV3rev 5
 
9
 
 TCCCCCCGGGTTAGCCTTCCCT-
TCGCAGCACC 3
 
9
 
, for in frame insertion into the COOH-terminal
green fluorescent protein (GFP) fusion vector, pEGFP-C1 (CLONTECH
Laboratories).
Further truncations of Cav3
 
KSY
 
 were similarly prepared using the fol-
lowing combinations of primers; Cav3
 
IYS
 
 (residues 120–151) and Cav3
 
IRT
 
(residues 125–151) used the forward primers, IYSfor 5
 
9
 
 GGAATTC-
CATCTACTCACTGTGTATCCGC 3
 
9
 
 and IRTfor 5
 
9
 
 GGAATTCCAT-
CCGCACCTTCTGC 3
 
9
 
 respectively, with the reverse primer CAV3rev.
Cav-3
 
D
 
C, a COOH-terminal truncation mutant of cav-3 (residues 1–107)
was generated using the forward primer, CAV3GFPfor 5
 
9
 
 CCGGAAT-
TCAATGATGACCGAAGAGCACACGG 3
 
9
 
, and the reverse primer,
CAV
 
D
 
Crev 5
 
9 
 
TCCCCCGGGTTAAATGCAGGGCACCACGGC 3
 
9
 
.
Full-length cav-3 was similarly produced using the forward primer,
CAV3GFPfor, and the reverse primer, CAV3rev. The products were then
cloned into pBluescript (Stratagene) and subcloned into pEGFP-C1. The
sequences of all constructs were confirmed by sequencing of both strands
in pBluescript using the T3 and T7 primers.
BHK, FRT, C2C12, and CV-1 cell lines were transiently transfected us-
ing Lipofectamine (GIBCO BRL) according to the manufacturer’s in-
structions. In brief, cells were grown to 
 
z
 
50% confluence on coverslips
and 10-cm dishes for immunofluorescence and electron microscopy, re-
spectively, or 90% confluence on 10-cm dishes for biochemical analysis.
The cells were washed twice with serum-free media before being trans-
fected with a ratio of 1 
 
m
 
g DNA to 5 
 
m
 
l Lipofectamine per 1 ml of Opti-
MEM (GIBCO BRL). The transfection mixture was left on the cells for
6 h before being washed with, and changed to, normal growth media lack-
ing antibiotics and incubated for a further 18 h before fixation or harvest-
ing. Nocodazole treatment was at a concentration of 10 
 
m
 
M for 2 h at 37
 
8
 
C
before fixation.
 
Preparation of Crude Fractions
 
Confluent dishes of cells were washed twice with cold PBS before being
 
scraped into ice-cold HES homogenization buffer (0.25 M sucrose, 1 mM
EDTA, and 20 mM Hepes, pH 7.4) containing protease inhibitors. Cells
were homogenized by passaging through a 27-G syringe and nuclei and
unbroken cells were removed by centrifugation at 1,000 
 
g
 
 for 5 min at 4
 
8
 
C.
The resulting supernatant was then centrifuged at 100,000 
 
g
 
 for 30 min at
4
 
8
 
C to separate cytosol (supernatant) from cellular membranes (pellet).
For Western analysis the pellet was extracted with a volume of 1% SDS
HES or 1% Triton X-100 HES equal to the volume of supernatant for 10
min at ambient temperature followed by centrifugation at 10,000 
 
g
 
 for 5
min at to remove insoluble material. Similarly, salt extractions were per-
formed on the pellet with volumes of 1 M KCl in 50 mM Tris, pH 8.0, or
0.1 M Na
 
2
 
CO
 
3
 
, pH 11.5, equal to the supernatant. Triton X-114 phase sep-
aration was achieved using the method of Bordier (1981), with the excep-
tion that membranes (100,000-
 
g
 
 pellet) were resuspended in the initial so-
lution.
 
Western Blotting
 
Equal volumes of cytosol (100,000-
 
g
 
 supernatant) and the detergent ex-
tracted microsomal membranes (100,000-
 
g
 
 pellet) were boiled in SDS
PAGE sample buffer. After electrophoresis proteins were transferred
to Immobilon membrane (Millipore Corp.) using a Bio Rad trans blot
semidry transfer cell. Membranes were blocked with 5% nonfat dry milk
TBS-T (0.15 M NaCl, 0.1% Tween 20, and 20 mM Tris, pH 7.4) followed
by incubation in specific antibody diluted in 1% nonfat dry milk TBS-T.
After washing with TBS-T membranes were incubated with a second anti-
body diluted in 0.2% BSA TBS-T. Bound antibody was detected using the
enhanced chemiluminescence detection system (Amersham Corp.).
 
Immunofluorescence Microscopy
 
Cells were grown on glass coverslips and fixed with either methanol
(
 
2
 
20
 
8
 
C, 
 
$
 
5 min) or 3% paraformaldehyde (PFA, 20
 
8
 
C, 
 
$
 
20 min). PFA-
fixed cells were permeabilized for 5 min with 0.1% (wt/vol) saponin in
PBS and labeled as described previously (Parton et al., 1997). For double
labeling with mouse and rabbit antibodies, cells were incubated with the
mixture of primary antibodies for 30 min, washed three times with PBS,
and incubated with a mixture of fluorescein- or Cy3-labeled anti–mouse
IgG and Cy3- or fluorescein-labeled anti–rabbit IgG for 20 min. In some
experiments, cells were double labeled with two rabbit antibodies (p23
and anti-concav). This was perfomed using the following sequence: anti-
concav, Cy3 goat anti–rabbit, a blocking irrelevant rabbit antibody (anti-
cholera toxin), then biotinylated rabbit anti-p23 followed by streptavi-
din-Cy2 (Monarch Medical). Control experiments omitting the primary
antibodies showed the specificity of the labeling. Samples were analyzed
with a confocal laser scanning microscope (Bio Rad Laboratories) equipped
with an argon and a helium/neon laser for double fluorescence at 488 and
543 nm. Fluorescein/Cy2 and Cy3 signals were recorded sequentially
(emission filters: BP510-525 and LP590) using 63 or 100
 
3
 
 plan-APO-
CHROMAT oil immersion objectives. For overlay, fluorescein and Cy3
images were adjusted to similar output intensities and merged with Adobe
Photoshop 3.0.5 into a composite RGB image using a Power Macintosh
7500/100 computer. Figures were arranged with Microsoft PowerPoint.
Colocalization was quantitated by analysis of confocal images of dou-
ble-labeled nocodazole-treated cells in which individual puncta were
clearly evident (e.g., see Fig. 4). Images were digitally captured and over-
laid using the RGB function of Adobe Photoshop. Separate images were
adjusted to equivalent intensities. IP Lab Spectrum software was then
used to analyze the images for the area occupied by the colocalizing ele-
ments as a percentage of the total labeled area. Results are expressed as
the mean of five fields 
 
6 
 
SEM. Note that this technique allows a compari-
son of the degree of overlap of different markers but underestimates the
actual puncta which are positive for both markers (e.g., cav/p23 showed a
63% colocalization but 
 
.
 
90% of puncta were labeled for both markers;
see for example Fig. 4).
 
Electron Microscopy
 
Cells were fixed with 8% paraformaldehyde in 100 mM phosphate buffer,
pH 7.35, or with the same fixative containing 0.1% glutaraldehyde for 30
min at RT and then processed for frozen sectioning as described previ-
ously (Parton et al., 1997). BSA-gold was internalized as a fluid phase
marker for 10 min or 30 min at 37
 
8
 
C as described previously (Kobayashi
et al., 1998). 
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Results
 
Localization of Expressed Epitope-tagged Cav-1 and 
Cav-3, and Endogenous Cav-1 in Cultured Cells
 
We have previously shown that cav-1 is localized to the
Golgi complex and to surface caveolae when expressed in
BHK cells (Dupree et al., 1993). We investigated the use
of a transfection approach to express caveolin mutants to
study caveolin targeting. As caveolin can form homo-oli-
gomers which could potentially influence the distribution
of introduced caveolins, we investigated the use of cav-3 to
study caveolin targeting as BHK cells lack endogenous
cav-3. Previous work using GST-fusion proteins of caveo-
lin has shown that cav-1FL or COOH- or NH
 
2
 
-terminal
truncation mutants can oligomerize with full-length cav-1
but not cav-3 (Song et al., 1997). Also in vivo cav-1 is
sorted away from cav-3 when expressed in differentiating
muscle cells (Parton et al., 1997).
Epitope-tagged cav-1 and cav-3 were expressed in BHK
cells. As shown in Fig. 1, A and B, cav-1 and cav-3 showed
a similar distribution as judged using antibodies against a
COOH-terminal epitope tag (VSV-G and HA, respec-
tively). The proteins were localized to the cell surface and
to a perinuclear compartment, assumed to represent the
Golgi complex (Dupree et al., 1993; see below). A similar
distribution was observed upon expression of a fusion pro-
tein comprising GFP fused to the NH
 
2
 
 terminus of cav-3
(Fig. 1 C). These results suggest that heterologously ex-
pressed cav-1 and cav-3 localize to the same compartments
in BHK cells and can be used to study caveolin targeting.
To further investigate the subcellular localization of ca-
veolin, we examined the distribution of endogenous cave-
olin using a number of different antibodies and cell lines.
Previous studies differ in their analysis of caveolin distri-
bution; some studies have shown that caveolin is only
present at the cell surface unless cells are subjected to ex-
perimental manipulations (Smart et al., 1994), whereas
others have concluded that caveolins exist in Golgi com-
plex–associated and surface pools at steady state (Dupree
et al., 1993). BHK, Vero, and MDCK cell lines as well as
primary human fibroblasts, which have been extensively
studied by others (Smart et al., 1994), were labeled with
antibodies to the NH
 
2
 
 terminus of cav-1 (anti-cav1N) and
antibodies to the COOH terminus (anti-cav1C). Similar
labeling patterns were observed in all the cell types stud-
ied; surface staining by anti-cav1N (e.g., human fibro-
blasts, Fig. 1 D) and a striking Golgi-type staining with
anti-cav1C antibodies (Fig. 1 E). This suggests that differ-
ent epitopes are exposed at these two cellular locations.
To investigate this possibility further we studied the ex-
posure of a domain of the molecule which has already
been extensively studied in terms of interacting proteins,
by raising antibodies against the scaffolding domain of the
caveolin family. This domain is conserved between caveo-
lins, thereby acting as a signature motif, and is also con-
served in evolution (Tang et al., 1997). Antibodies were
raised in rabbits against a scaffolding domain peptide cor-
responding to the sequence of cav-3 (see Materials and
Methods) and affinity purified on the corresponding pep-
tide column. By Western blotting the affinity-purified anti-
body (anti-concav) recognized a doublet of 
 
z
 
21 kD in
BHK membranes (Fig. 2 A), a single band in undifferenti-
ated C2C12 myoblast membranes, and a single 
 
,
 
20-kD
band in differentiating C2C12 myotubes (Fig. 2 B). The
Figure 1. Localization of
overexpressed epitope-tagged
caveolins and endogenous
cav-1 in BHK cells and fi-
broblasts. (A–C) BHK cells
were transfected with VSV-G
epitope-tagged cav-1 (cav1(G)),
HA-tagged cav-3 (cav3(HA)),
or with a fusion protein com-
prising GFP fused to the NH2
terminus of cav-3 (cav3(GFP))
as indicated. The full-length
caveolin constructs localize
to the cell surface and peri-
nuclear area. (D and E) Im-
munofluorescent detection of
cav-1 in human fibroblasts.
Cultured human fibroblasts
were labeled with antibodies
directed against either the
NH2 terminus or COOH ter-
minus of cav-1 as indicated.
Whereas the NH2-terminal
antibodies show a character-
istic surface staining, anti-
bodies against the COOH
terminus show a Golgi-like
staining pattern. Bars, 10 mm. 
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signal was completely competed by the specific peptide to
which it was raised (not shown). This suggested that the
antibody (named anti-concav for consensus caveolin) rec-
ognized both cav-1 and cav-3, the predominant isoforms
expressed in BHK cells and C2C12 myoblasts, and differ-
entiating C2C12 myotubes, respectively. This was con-
firmed by blotting of BHK cells overexpressing cav-1 or
cav-3 (Fig. 2 C). By immunofluorescence the antibody was
shown to recognize overexpressed cav-1, cav-2, and cav-3
(Fig. 3, A–C) consistent with the predicted specificity.
The anti-concav gave a characteristic perinuclear stain-
ing on cell lines including BHK, CV-1, and MDCK (Fig. 3,
D–F). Primary human fibroblasts revealed the same pat-
tern of labeling which colocalized with the Golgi marker,
p23 (Fig. 3, G–I). This staining pattern was distinct from
that obtained with antibodies to the NH
 
2
 
 terminus of cav-1,
which as expected gave a surface staining pattern charac-
teristic of caveolae (Fig. 1 D). This result suggested that
the anti-concav antibody was unable to recognize surface
caveolin. To test this possibility, we examined the staining
pattern for anti-concav in differentiating C2C12 cells. In
these cells cav-3 gives a characteristic staining pattern rep-
resenting the surface-connected T-tubule system (Parton
et al., 1997). The cav-3(N) antibody showed the charac-
teristic reticular staining pattern as described previously
(Parton et al., 1997) but the anti-concav showed no label-
ing of the T-tubules (results not shown). We then exam-
ined whether the strict specificity for intracellular caveolin
was retained after overexpression, when interaction with
surface molecules might be expected to be saturated. Even
after high overexpression of cav-3 using the recombinant
SFV expression system, the strict specificity of the concav
antibody for the intracellular caveolin pool was still main-
tained with no sign of surface staining (compare Fig. 3 J,
anti-cav-3(N) with Fig. 3 K, anti-concav). These experi-
ments, in which antibody concentrations were optimized
to allow only detection of overexpressed caveolin, also
emphasize that the N- and concav antibodies were both
recognizing the same heterologously expressed caveolin.
In summary, the results suggest that the anti-concav and
anti-cavC antibodies specifically recognize Golgi-associ-
ated caveolin and that changes in the accessibility or con-
formation of the epitope on transport of caveolin to the
cell surface may inhibit antibody binding.
 
Antibodies to the COOH Terminus of Caveolin-1, to 
Concav, or to Purified Caveolin Localize to the
Cis-Golgi Complex
 
In view of the different models for caveolin cycling, we
sought to pinpoint the domain of the Golgi complex with
which caveolin was associated. For this analysis we used a
monoclonal commercial antibody against purified cav-1
(anti-cav1FL; see Fig. 4 A) together with either a cis-Golgi
marker p23 (Rojo et al., 1997) or a TGN marker (trans-
fected sialotransferase, tST; Rabouille et al., 1995). We
found that cav-1 immunolabeling colocalized with the
TGN marker tST in control cells as judged by confocal mi-
croscopy, consistent with previous studies; (Dupree et al.,
1993), but the same high degree of colocalization was
found with p23 (not shown). Therefore, we employed the
microtubule-depolymerizing agent, nocodazole, which has
been shown to disrupt the Golgi complex (Kreis, 1990)
and has been used to localize proteins to distinct Golgi
sub-compartments (e.g., Chavrier et al., 1990; Ullrich et al.,
1996). Nocodazole treatment caused dispersion of Golgi
markers into discrete puncta (Fig. 4). Double labeling of
nocodazole-treated cells with cis- (p23) and trans-Golgi
(tST) markers showed clear, although incomplete, segre-
gation of the two markers (Fig. 4 B; note that many of the
puncta are only labeled for one of the markers). After no-
codazole treatment anti-cav1FL showed a relatively low
degree of colocalization with tST (Fig. 4 D) but almost
complete colocalization with p23 (see Fig. 4 C; virtually all
p23 puncta are caveolin-positive). The level of colocaliza-
tion was also quantitated as the area occupied by the colo-
calizing elements in the image as a percentage of the total
labeled elements (see Materials and Methods for details).
Consistent with the qualitative data, these results showed
Figure 2. Characterization of an antibody to the conserved scaf-
folding domain of caveolins. Antibodies raised against either the
conserved domain of cav-3 (anti-concav), the cav-1 NH2 terminus
(anti-cav1(N)), or the cav-3 NH2 terminus (anti-cav3(N)) were
used to blot BHK cell membranes (A), C2C12 myoblasts, and
myotube membranes (B) or BHK cells overexpressing cav-1 or
cav-3 (C). (A) The anti-concav antibody detects a doublet in
BHK membranes, the upper band comigrating with the longer
(a) form of cav-1 as shown with the anti-cav1(N) antibody. (B)
Anti con-cav recognizes a z21-kD band in undifferentiated
C2C12 myoblasts (MB) and a ,20-kD band in differentiating
C2C12 myotubes (MT; B, d0, d1, and d2 indicate days of differ-
entiation). The adjacent blot shows the same fractions probed
with anti-cav3(N). (C) Cells expressing cav-1 (1) or cav-3 (3)
were probed with the antibodies indicated. The anti-concav anti-
body recognizes both overexpressed cav-1 and cav-3. 
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a much higher degree of colocalization for caveolin/p23
(63
 
 6 
 
4%) than for caveolin/tST (46
 
 6 
 
6%) or p23/tST (41
 
 6
 
4%). This suggests caveolin is present in the early Golgi
and is not exclusively present in the TGN.
The subcellular location was further analyzed by immu-
noelectron microscopy. All the available antibodies gave
low labeling of the Golgi complex on ultrathin frozen sec-
tions of intact cells. However, in frozen sections of BHK
cell fractions enriched for p23 and ERD2 (Rojo et al.,
1997), anti-cavC labeling colocalized with p23 on Golgi
cisternae (Fig. 5). The higher labeling in this preparation
presumably reflects greater accessibility of cytosolic epi-
topes as described for other Golgi proteins (Griffiths et
al., 1994). Taken together the results show that under
steady state conditions caveolin is detectable within the
cis-Golgi.
Figure 3. Immunofluores-
cence detection of caveolin
using the anti-concav anti-
body. (A–C) FRT cells were
infected with recombinant
Semliki Forest Virus express-
ing cav-1 (A), cav-2 (B), or
cav-3 (C). The cells were
then labeled with affinity pu-
rified anti-concav antibodies
and examined by confocal
microscopy. The antibody
recognizes all three caveolins
by immunofluorescence. (D–
F) A number of cell types
were labeled with the anti-
concav antibody as follows;
BHK (D), CV-1 (E), MDCK
(F), and primary human fi-
broblasts (G–I). In each case
labeling is only detectable in
the perinuclear area of the
cell consistent with a Golgi
localization pattern. This was
confirmed by double labeling
with a cis-Golgi marker, p23
in the human fibroblasts (H
and I). (J and K) Immunoflu-
orescence detection of over-
expressed caveolin-3 with
anti-cav3(N) and anti-con-
cav antibodies. BHK cells
were infected with recombi-
nant SFV to express cav-3.
The cells were then fixed and
labeled with anti-cav3(N) an-
tibodies (J) and anti-concav
antibodies (K) and examined
by confocal microscopy. Note
the dramatic difference in
the labeling patterns; surface
and possible internal staining
in J but only Golgi staining in
K. Bars, 10 mm. 
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Mutational Analysis of Caveolin Targeting: Targeting of 
an NH
 
2
 
-terminal Deletion Mutant
 
We examined whether a specific region of the caveolin
molecule is responsible for the localization of caveolin to
the Golgi complex. To avoid potential problems of associ-
ation with endogenous caveolins (Song et al., 1997) we
prepared mutants of cav-3 which are not endogenously ex-
pressed in BHK cells. A series of cav-3 deletion mutants
with a COOH-terminal HA tag were prepared (see Fig. 6
A) and expressed transiently in BHK cells. As shown in
Fig. 6, C–F, the NH
 
2
 
-terminal deletion mutants showed
overlapping but distinct localization patterns with varying
degrees of surface and intracellular labeling. Most strik-
ingly, Cav3
 
DGV
 
, which lacks the NH
 
2
 
-terminal region up to
the scaffolding domain (residues 54–151), showed no hint
of surface labeling and this mutant was chosen for more
detailed analysis. Cav3
 
DGV
 
 localized to the Golgi appara-
tus and to punctate structures throughout the cell. This
was examined in more detail by immunoelectron mi-
croscopy using antibodies to the HA tag (Fig. 7). Consistent
with the confocal microscopic analysis, Cav3
 
DGV
 
 was shown
to associate with the Golgi complex (Fig. 7) as well as
Figure 4. Immunofluores-
cent detection of cav-1 and
Golgi markers in BHK cells
after nocodazole treatment.
BHK cells were treated with
nocodazole to cause Golgi
dispersion. (A) Cells were
double labeled for endoge-
nous caveolin using commer-
cial monoclonal antibodies to
caveolin-1 (cav1(FL)) and
the affinity-purified concav
antibody. The two antibodies
colocalize throughout the
cell. (B) The efficiency of
Golgi marker separation by
nocodazole was examined
by comparing a cis-Golgi
marker, p23, and expressed
sialotransferase (B). Endog-
enous p23 and expressed si-
alotransferase were partially
separated after nocodazole
treatment (note fewer yellow
structures and greater num-
ber of green and red dots in
B overlay). (C and D) Cells
were double labeled with
cav-1(FL) and with p23 (C)
or expressed sialotransferase
(D) before examination by
confocal microscopy. Note
the higher degree of colocal-
ization (indicated by the
greater number of yellow
dots) of caveolin with the cis
marker, p23, than with the
trans marker, ST. Bars, 10 mm. 
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intracellular vesicular elements (Roy et al., 1999). The
Golgi labeling colocalized with ERD2 (KDEL-receptor)
showing that the protein was concentrated in the cis-
Golgi complex (Fig. 7 B). In a small proportion of highly
expressing cells labeling was also observed within the
endoplasmic reticulum (not shown).
 
Targeting of a COOH-terminal Caveolin Domain
 
These studies suggest that Golgi targeting/retention in-
formation resides in the COOH-terminal portion of the
molecule. To identify the relevant domain we expressed a
construct comprising just the putative COOH-terminal
cytoplasmic domain of cav-3 (residues 108–151). This
domain has previously been assigned as cytoplasmically
orientated based on amino acid sequence predictions, on
antibody recognition of the COOH-terminal domain in
permeabilized cells (Dupree et al., 1993), and in vitro
 
 
 
im-
port experiments (Monier et al., 1995). The construct
termed Cav3
 
KSY
 
 was expressed in BHK cells with an HA
epitope tag. Cav3
 
KSY
 
 was targeted specifically to the peri-
nuclear area of the cell (Fig. 6 F). No surface staining was
apparent in contrast to the full-length protein expressed
under the same conditions. In very highly expressing cells
a cytoplasmic staining in addition to the Golgi complex
was apparent (not shown).
The specific localization of this mutant was confirmed
by immunoelectron microscopy (Fig. 8). Expressing cells
showed Golgi labeling for the expressed protein. No label-
ing was associated with the plasma membrane or other or-
ganelles. Very high expressing cells showed dispersed cy-
tosolic staining throughout the cell in addition to the Golgi
staining but unlike Cav3
 
DGV
 
-expressing cells, Cav3KSY ex-
pressing cells never showed ER staining. Together with
the immunofluorescence results this suggests that the asso-
ciation of this caveolin fragment with the Golgi complex is
a saturable process.
We then localized the Cav3KSY mutant with respect to
the defined Golgi markers p23, tST, and giantin (Linstedt
and Hauri, 1993) at the light and electron microscopic
levels. The Cav3KSY colocalized with all three markers in
untreated cells (Fig. 9, A–F). However, after nocoda-
zole treatment, colocalization with cis markers was more
complete than with the medial or trans Golgi markers (Fig.
10, A–I). This confirms that the localization of Cav3KSY
closely follows that of endogenous cav-1 and suggests
that the Cav3KSY is not mislocalized to an irrelevant do-
main. We also examined the distribution of Cav3KSY at
the electron microscopic level with respect to defined
markers. Cav3KSY showed a clear colocalization with the
cis-Golgi markers p23 (Fig. 8, B and C) and with ERD2
(not shown). In extracted cells (e.g., Fig. 8 C) labeling
was clearly shown to be associated with the cytoplasmic
face of the membrane.
The distribution of Cav3KSY with respect to endogenous
caveolin was also examined. Cav3KSY showed colocaliza-
tion, as judged by confocal immunofluorescence micros-
copy, with antibodies to the COOH terminus of caveolin
(Fig. 9, G and H). In contrast, as expected antibodies to
the NH2 terminus of caveolin which only label the surface
caveolin, showed no colocalization with Cav3KSY (not
shown). A consistent observation in the Cav3KSY-express-
ing cells was a dramatic decrease in the endogenous Golgi
caveolin labeling in a subpopulation (30–40%) of express-
ing cells (Fig. 9, I and J). This decrease appeared unrelated
to expression levels and was observed with different label-
ing sequences, in combination with nocodazole treatment
(Fig. 9, K and L) and with the three different antibodies
against caveolin which recognize different domains of the
molecule. This suggests that the association of Cav3KSY
with the Golgi complex either decreases accessibility of ca-
veolin antibodies to the endogenous caveolin or, more
likely, decreases the Golgi-associated pool of caveolin.
Although the oligomerization of caveolin has been
shown to be isotype-specific in vitro (Song et al., 1996), the
possibility remained that the Golgi-association of Cav3KSY
could represent association with endogenous Golgi caveo-
lin. To test this in vivo we made use of the epithelial cell
line, FRT, which lacks caveolin and caveolae (Lipardi et al.,
1998). Cav3KSY expressed in these cells showed the charac-
teristic staining of the Golgi complex (Fig. 11, A and B)
which colocalized with p23 (not shown), strongly suggest-
ing that the association of Cav3KSY is independent of en-
dogenous caveolin. This was further tested by double
transfection of Cav3KSY and wild-type cav-1 or GFP-
tagged cav-3. Cav3KSY colocalized with the expressed pro-
Figure 5. Immunoelectron
microscopic localization of
caveolin in Golgi fractions
from BHK cells. Thawed
cryosections of Golgi frac-
tions prepared according to
(Rojo et al., 1997) were dou-
ble labeled with antibodies to
p23 followed by 15 nm pro-
tein A–gold and anti-cavC
followed by 10 nm protein
A–gold. The two Golgi
stacks show polarized label-
ing for p23 and for caveolin
(arrowheads) as shown at
higher magnification in B.
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teins in the Golgi complex but even after high overexpres-
sion of full-length cav-3, Cav3KSY was not recruited to the
cell surface (not shown). To examine whether removal of
the COOH terminus of Cav-3 caused a loss of Golgi local-
ization, Cav-3DC with an NH2 terminal GFP tag was ex-
pressed in BHK cells. The protein showed only a reticular
staining pattern consistent with an ER localization (not
shown). Although these results are consistent with a role
for the COOH terminus in association of caveolin with the
Golgi complex they could indicate a general perturbation
of folding/oligomerization leading to lack of transport
from the ER. Nevertheless our results show that the
COOH-terminal cytoplasmic domain of caveolin associ-
ates in a saturable fashion with the cis-Golgi complex.
Cav3KSY Can Target a Heterologous Cytoplasmic 
Protein to the Golgi Complex
To investigate whether the COOH terminus of cav-3 could
target a heterologous protein to the Golgi complex, a fu-
sion protein comprising Cav3KSY fused to the COOH ter-
minus of GFP was prepared. The GFP-Cav3KSY fusion
protein was expressed in BHK cells under a CMV pro-
moter. The fusion protein was specifically targeted to the
Golgi complex (Fig. 11 C) where it colocalized with p23
(not shown). In the majority of cells cytoplasmic staining
was also apparent consistent with saturation of the target-
ing machinery (Fig. 11 C). In addition, in higher expressing
cells GFP-Cav3KSY labeled the periphery of large vesicular
structures in the perinuclear area of the cell (Fig. 11 D).
These experiments show that the COOH-terminal domain
of cav-3 is sufficient to localize a heterologous cytosolic
protein to the Golgi complex.
We carried out a preliminary characterization of the re-
gions of the COOH-terminal cytoplasmic domain which
were required for Golgi location by expressing COOH-
terminal fragments as fusion proteins with GFP. A 32–
amino acid segment (Cav3IYS; see Fig. 6 B) fused to GFP
showed the characteristic staining pattern of the Golgi
complex (Fig. 11 E). In contrast, all cells expressing the
Cav3IRT mutant, which lacks the first five amino acids of
Cav3IYS (see Fig. 6 B), consistently showed dispersed la-
beling throughout the cell (Fig. 11 F). The observed differ-
ences between the two mutants were independent of ex-
pression level. In conclusion we have identified a unique
domain of the caveolin molecule which can target a heter-
ologous protein to a specific domain of the Golgi complex.
Figure 6. Diagrammatic rep-
resentation and immunofluo-
rescent detection of cav-3
mutants. (A) Summary of
some of the mutants used in
this study and their predicted
topology. (B) Amino acid se-
quence of putative COOH-
terminal domain of cav-3
with additional COOH-ter-
minal mutants. (C–F) BHK
cells were transfected with a
series of HA-tagged caveo-
lin-3 mutants as follows:
Cav3DIH (panel C), Cav3NED
(D), Cav3DGV (E), and
Cav3KSY (F). They were then
labeled with antibodies to
the HA tag and examined by
confocal microscopy. While
there is clearly surface stain-
ing and internal staining in A
and B, the Cav3DGV con-
struct (E) shows no surface labeling but only perinuclear labeling
and punctate cytoplasmic staining. Cav3KSY (F) lacks the punc-
tate labeling but also labels the perinuclear region of the trans-
fected cells. Note that in some higher expressing cells labeling is
apparent throughout the cytosol. Bar, 10 mm.The Journal of Cell Biology, Volume 145, 1999 1452
Caveolin COOH-terminal Constructs Show Tight 
Binding to Membranes: Putative Role for 
Palmitoylation in Golgi Association
Finally, we examined the nature of the association of
Cav3KSY with the Golgi complex. BHK cells expressing
Cav3KSY were harvested, homogenized, and separated by
centrifugation into crude cytosol and membrane fractions.
Membranes were initially extracted with buffer containing
1% SDS or 1% Triton X-100. Fig. 12 A shows that both
these detergents extracted a peptide of z5 kD recognized
Figure 7. Immunoelectron
microscopic localization of
HA-tagged cav3DGV in BHK
cells. BHK cells were trans-
fected with the cDNA for
HA-tagged cav3DGV and the
overexpressed protein de-
tected with antibodies to the
HA tag. Cells were incu-
bated with 5 nm BSA-gold
for 10 min at 378C before fix-
ation. Thawed cryosections
were labeled with antibodies
to the HA tag followed by 15
nm protein A–gold. In panel
B the sections were also la-
beled with antibodies to
ERD2 followed by 10 nm
protein A–gold. A shows a
low magnification view of the
perinuclear region of the cell
showing specific labeling for
the HA-tagged cav3DGV in
the Golgi complex (g). As
shown in panel B this label-
ing colocalizes with the cis-
Golgi marker, ERD2 (10 nm
gold, arrowheads). Labeling
is also associated with vesicu-
lar structures (not shown).
Negligible labeling was asso-
ciated with the plasma mem-
brane (p), mitochondria (m),
and early endosomes labeled
by 5 nm BSA-gold (arrows).
N, nucleus. Bars, 100 nm.Luettterforst et al. Association of Caveolins with the Golgi Apparatus 1453
by the anti-HA antibody which was not present in mock
transfected control cells. Treatment with either 1 M KCl
or alkaline 0.1 M Na2CO3 both failed to extract Cav3KSY
from the pellet (Fig. 12 B). To confirm the apparent hy-
drophobicity of Cav3KSY the membranes were treated with
Triton X-114 which enables phase separation of am-
phiphilic from hydrophilic proteins. Fig. 12 C shows that
Cav3KSY was detected only in the amphiphilic Triton X-114
phase. We then examined the membrane association of
the GFP-Cav3KSY chimera. While expressed WT-GFP
was predominantly in the soluble fraction, as predicted for
a cytosolic protein, the majority of GFP-Cav3KSY was tar-
geted to the membrane fraction (Fig. 12 D).
Cav-1 has been shown to be palmitoylated and so we ex-
amined whether this lipid modification might be required
for the Golgi localization of the COOH-terminal caveolin
fragment. A full-length cav-1 construct in which the three
COOH-terminal palmitoylated cysteines have been mu-
Figure 8. Immunoelectron
microscopic localization of
HA-tagged Cav3KSY in BHK
cells. BHK cells were trans-
fected with the cDNA for
HA-tagged Cav3KSY and the
overexpressed protein de-
tected with antibodies to the
HA tag. Thawed cryosections
were labeled with antibodies
to the HA tag followed by 15
nm protein A–gold. In B, the
sections were also labeled
with antibodies to p23 fol-
lowed by 10 nm protein
A–gold (arrows). In C, sec-
tions were labeled for HA
with 10 nm gold (arrowheads)
and p23 with 15 nm gold. A
shows a low magnification
view showing specific label-
ing for the HA-tagged cav3KSY
in the Golgi complex (g). As
shown in B this labeling co-
localizes with the cis-Golgi
marker, p23 (10 nm gold). C
shows the Golgi complex of
an extracted cell in which the
p23 labeling is greatly in-
creased as compared with un-
extracted cells. The polarity
of the p23 and the HA-tagged
Cav3KSY (arrowheads) is
clearly evident. Negligible la-
beling was associated with
the plasma membrane (p).
Bars: (A) 500 nm; (B and C)
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tated to alanine (Cav-1Cys-Ala) has already been de-
scribed and characterized (Dietzen et al., 1995; Monier et al.,
1996). We used a WT cav-1 construct to generate the cav-1
equivalent of the Cav3KSY (Cav-1KSF) and the Cav-1Cys-
Ala cDNA to generate the corresponding Cys-Ala mutant
(Cav-1KSFDp). Each construct incorporated a COOH-ter-
minal HA-tag. The constructs were expressed in BHK
cells and their distribution examined by immunofluores-
Figure 9. Colocalization of
HA-tagged Cav3KSY with
Golgi markers and caveolin
in BHK cells. Cav3KSY trans-
fected BHK cells were dou-
ble-labeled with antibodies
to the HA epitope (A, C, E,
G, I, and K) and with anti-
bodies against a cis-Golgi
marker, p23 (B), medial-
Golgi marker giantin (D),
TGN marker sialotransferase
(F), and caveolin (cav1C; H,
J, and L). Cells were then ex-
amined by confocal micros-
copy. Colocalization is evi-
dent with all three Golgi
markers (A–F). (G–L) Im-
munolocalization of HA-
tagged Cav3KSY and endoge-
nous cav-1. In many cells the
HA-tagged cav3KSY and the
caveolin colocalize (G and
H). However, a consistent
observation was that in many
of the Cav3KSY transfected cells (varying between 30 and 40%; five independent experiments) the endogenous cav-1 signal was dimin-
ished or undetectable (I and J). Treatment with nocodazole did not abrogate this signal loss (K and L). Bars, 10 mm.
Figure 10. Immunolocaliza-
tion of HA-tagged Cav3KSY
in transfected BHK cells
treated with nocodazole to
cause Golgi dispersion. BHK
cells were transfected with
HA-tagged Cav3KSY or dou-
ble transfected with HA-
tagged Cav3KSY and sialo-
transferase, and then were
treated with 10 mM nocoda-
zole for 2 h before fixation to
obtain separation of Golgi
markers. The cells were then
double labeled with antibod-
ies to the HA tag and with
antibodies to either p23
(A–C), giantin (D–F), or
epitope-tagged sialotrans-
ferase (ST; G–I). The cells
were then examined by con-
focal microscopy. Close ex-
amination of the overlays
(shown in C, F, and I) show
that the colocalization of the
HA tag with p23 (A–C) is
more complete than with gi-
antin (D–F) or tST (G–I)
(compare the relatively high
proportion of completely yel-
low dots in C as compared
with F and more strikingly,
I). Bar, 10 mm.Luettterforst et al. Association of Caveolins with the Golgi Apparatus 1455
cence. As expected the Cav-1KSF was specifically local-
ized to the Golgi complex consistent with the results
with the cav-3 constructs (Fig. 11 G). In contrast, cells express-
ing Cav-1KSFDp did not show a characteristic Golgi stain-
ing (Fig. 11 H) although both Cav-1KSF and Cav-1KSFDp
were membrane associated as judged biochemically (not
shown). These results suggest a role for palmitoylation
in the specific association of the COOH terminus of ca-
veolin with the Golgi complex.
Discussion
Crucial to understanding the role of caveolins is the deter-
mination of the exact cellular distribution and intracellular
itinerary of this family of proteins. In the present study we
have localized caveolin using different specific antibodies
and analyzed the targeting information in the caveolin
molecule. In particular, we have shown that in addition to
surface caveolae, caveolin is also associated with the cis-
Golgi in all cell types studied. However, different epitopes
are exposed in these locations. We have then used a muta-
tional approach to examine caveolin cycling and targeting.
The NH2 terminus of the protein was shown to be required
for caveolae targeting while the COOH terminus contains
a Golgi targeting motif which is sufficient to target a heter-
ologous protein to the Golgi.
Caveolin has been shown to play an important role in
signal transduction at the cell surface and many signaling
molecules have been postulated to interact with caveolin
directly. Upon cell transformation caveolin levels decrease
(Koleske et al., 1995) and it has also been shown that cave-
olin is phosphorylated upon Rous sarcoma virus transfor-
mation (Glenney, 1989; Li et al., 1996b) or upon stimula-
tion of adipocytes with insulin (Mastick et al., 1995;
Mastick and Saltiel, 1997). In view of these functions, pri-
marily assigned to the plasma membrane, it initially ap-
pears somewhat surprising that caveolin is cycling between
the cell surface and intracellular compartments. In fact
early studies suggested that caveolin was exclusively a sur-
face protein based on immunofluorescence and pre-embed-
ding immunoelectron microscopy (Rothberg et al., 1992).
Other studies showed that caveolin is associated with the
Golgi complex but this location was only visualized with
certain antibodies (Dupree et al., 1993) or with overex-
pressed protein (Kurzchalia et al., 1992). This labeling was
assigned to the TGN and exocytic vesicles consistent with a
conventional cycling pathway between the Golgi and the
cell surface. Later work outlined a quite distinct cycling
pathway for the caveolin molecule involving transport of
caveolin to the ER and cis-Golgi. In these studies caveolin
was associated with the plasma membrane in control cells
(human fibroblasts) but redistributed to intracellular com-
partments only upon treatment with cholesterol oxidase or
Figure 11. The COOH-terminal domain of cav-3 labels the Golgi
of FRT cells and can target a cytosolic protein to the Golgi com-
plex. (A and B) Immunofluorescence of HA-tagged Cav3KSY in
FRT cells. FRT cells, an epithelial cell line which expresses no
endogenous caveolin, were transfected with the HA-tagged
Cav3KSY. While many of these cells showed HA labeling through-
out the cytoplasm (A), all showed some association with perinu-
clear structures (B) which colocalized with p23 (not shown). (C
and D) Localization of GFP-Cav3KSY in transfected BHK cells.
BHK cells were transfected with a GFP-Cav3KSY fusion protein.
The majority of expressing cells show labeling throughout the cy-
toplasm in addition to a clear Golgi labeling (C). In some higher
expressing cells the Golgi appears to show morphological
changes (D). (E–H) BHK cells were transfected with caveolin
mutants as indicated and localized by confocal microscopy. (E
and F) transfected Cav3IYS (see Fig. 6) localizes to the Golgi com-
plex whereas Cav3IRT consistently showed a more diffuse stain-
ing, irrespective of expression levels. (G and H) Immunolocalization
of Cav-1KSF and the palmitoylation-deficient mutant Cav-1KSFDp.
Cav-1KSF generally showed a characteristic Golgi labeling pattern
while those transfected with Cav-1KSFDp consistently gave a more
diffuse cytoplasmic labeling. Bars, 10 mm.The Journal of Cell Biology, Volume 145, 1999 1456
nocodazole (Smart et al., 1994; Conrad et al., 1995). Subse-
quent studies have raised the possibility that the primary
function of caveolin in mammalian cells is to regulate cho-
lesterol transport (Fielding and Fielding, 1997). To under-
stand these processes it is essential that the caveolin distri-
bution and routing is determined and the molecular
machinery defined. This study has started to address these
issues and to provide tools for further analysis.
First, we have shown that in all cell types studied a pool
of caveolin is present in the Golgi complex. However, our
studies demonstrate some of the difficulties associated
with localizing caveolin. Different antibodies clearly rec-
ognize different pools of the protein, at least as seen by im-
munofluorescence. Of particular interest is a new anti-
body, characterized here, which was raised against the
scaffolding domain of the caveolin molecule. This do-
main is highly conserved both in evolution (Tang et al.,
1997) and between different mammalian caveolins (Par-
ton, 1996) and consistent with this we have shown that it
recognizes all three mammalian caveolins. This domain
interacts with a number of signaling molecules (Li et al.,
1996a) and is also involved in self-association to form
oligomers (Sargiacomo et al., 1995). Remarkably, despite
these protein-protein interactions, the antibody gave a spe-
cific signal by immunofluorescence but only recognized
the Golgi form of the protein by this technique. A similar
specificity was seen with antibodies against the COOH ter-
minus. The molecular basis for the selectivity is unclear.
Oligomerization has been shown to occur early in the bio-
synthetic pathway immediately after cotranslational inser-
tion into the endoplasmic reticulum. We suspect that
higher order complexes of proteins and lipids might restrict
antibody accessibility. In fact, in ultrathin frozen sections,
antibodies against the COOH terminus or against the con-
served domain do recognize surface protein suggesting that
epitopes are exposed upon sectioning (results not shown).
This suggests that protein–protein interactions might not
be responsible for blocking accessibility. Whatever the
mechanism, it is apparent that care should be taken in in-
terpreting caveolin localization based on single antibodies.
We were also able to define the domain of the Golgi
with which the caveolin is detectable as the cis-Golgi com-
plex based on immunoelectron microscopic colocalization
with defined markers. This presumably represents a pool
of caveolin which cycles through the entire Golgi and
TGN to the surface as cav-1 has been detected within
Golgi derived exocytic vesicles (Kurzchalia et al., 1992)
and is directly implicated in exocytic transport to the api-
cal cell surface of epithelial cells (Scheiffele et al., 1998).
This implies that caveolin follows an unusual cycling path-
way to reach early compartments of the biosynthetic path-
way, distinct from that followed by molecules such as furin
and TGN38 (Chapman and Munro, 1994). In this way the
results are consistent with those showing redistribution of
caveolin in response to cholesterol oxidase or nocodazole
(Smart et al., 1994; Conrad et al., 1995). However, our re-
sults differ significantly in other ways. Most notably, in all
cell types studied including human fibroblasts as used in
the above studies, caveolin is not only detectable on the
surface but also in the Golgi complex under all conditions
tested. The distribution of surface caveolin was unchanged
by nocodazole treatment (not shown). Our subsequent ex-
periments were designed to analyze the Golgi association
of caveolin further and to determine the molecular basis of
this targeting through mutational analysis of the caveo-
lin molecule.
Mutational Analysis of Caveolin Targeting
We chose to analyze caveolin targeting using the muscle-
specific caveolin isoform, cav-3, expressed in BHK cells.
The first striking observation was that truncation mutants
lacking the first 54 amino acids no longer associated with
surface caveolae as determined by immunofluorescence
and immunoelectron microscopy with (COOH-terminal)
epitope-tagged constructs and with the (NH2-terminally)
Figure 12. Biochemical characterization of
Cav3KSY. (A) Detergent solubility of HA tagged
Cav3KSY. Western blotting was used to identify
the epitope tagged protein recognized by an anti-
HA antibody. No significant signal was observed
in the cytosol fraction. Analysis of membranes
(100,000-g pellet) extracted with 1% Triton
X-100 as well as 1% SDS shows a z5-kD band in
the transfected samples recognized by the anti-
HA antibody. (B) Comparison of supernatant
(s) and pellet (p) after extraction from mem-
branes (100,000-g pellet) with 1 M KCl and al-
kaline 0.1 M Na2CO3 showing Cav3KSY is re-
tained in the insoluble fraction. (C) Separation
of amphiphilic and hydrophilic proteins from
membranes with Triton X-114 shows Cav3KSY
partitioning into the Triton X-114 phase. (D)
Western blot with anti-GFP antibody showing
the relative distributions of transfected WT-
GFP, GFP-Cav3KSY, and GFP-Cav3(FL) in
BHK crude cytosol (s) and membrane (p) frac-
tions.Luettterforst et al. Association of Caveolins with the Golgi Apparatus 1457
GFP-tagged fusion protein. In contrast, the removal of the
first 33 amino acids had no effect on surface localization.
This may indicate that residues 33–54 are required for ca-
veolae targeting or retention or at least implies that re-
moval of the first 54 amino acids disrupts this process. Ex-
pression of the entire NH2 terminus produced a soluble
protein with no detectable association with membranes
(results not shown).
We then went on to analyze the domains of the caveolin
molecule required for Golgi association. Removal of the
NH2 terminus had no effect on Golgi localization of the
protein. Therefore, we investigated whether the COOH
terminus contains Golgi targeting information. Surpris-
ingly, the putative COOH-terminal domain associated with
the cis-Golgi even when expressed alone, presumably as a
soluble protein. Moreover, this domain was able to target a
heterologous soluble protein, GFP, to the Golgi. It is im-
portant to note that GFP was fused to the NH2 terminus of
the construct, in place of the putative intramembrane do-
main. The domain required for targeting GFP to the Golgi
was narrowed down to a relatively hydrophobic region of
32 amino acids of which the first five amino acids were es-
sential. This region showed no significant homology with
other Golgi associated proteins in amino acid sequence.
This small domain is sufficient for Golgi targeting and al-
though normally part of a membrane protein can appar-
ently function in the context of a soluble protein. This
property may not be so surprising in view of recent reports
that caveolin is not always an integral membrane protein
but can exist in a cytosolic complex with cholesterol and
chaperones (Uittenbogaard et al., 1998). Our morphologi-
cal studies suggest that association with the Golgi complex
is a saturable process as higher expressing cells showed la-
beling throughout the cell by both immunofluorescence
(particularly with the GFP-tagged construct) and by im-
munoelectron microscopy.
What is the molecular basis of the association with the
Golgi complex? Our studies show that the protein does
not associate with endogenous caveolins consistent with in
vitro studies of caveolin oligomer formation (Song et al.,
1997). The caveolin COOH terminus may therefore inter-
act with a specific Golgi component. Our biochemical
studies showed a surprisingly tight association with the
membrane. Detergent treatment, but not high pH sodium
carbonate, released the GFP-Cav3KSY fusion protein from
membranes. One possibility is that like cav-1 (Dietzen et al.,
1995; Monier et al., 1996), cav-3 is palmitoylated and this
modification is involved in Golgi membrane association.
Indeed, we showed that the corresponding domain of cav-1
also associates preferentially with the Golgi complex and
that this specific localization is lost upon modification of
the three COOH-terminal cysteines to alanines. These
three cysteine residues have been shown to be palmitoy-
lated in vivo and to play a role in stabilization of higher or-
der oligomers (Monier et al., 1996) but not to play a role in
targeting to caveolae (Dietzen et al., 1995; Monier et al.,
1996; Parton, R., and T. Kurzchalia, unpublished observa-
tion). Cav-1 can be palmitoylated on all three cysteine res-
idues within the COOH terminus (Monier et al., 1996).
While palmitoylation alone is unable to mediate specific
association with the Golgi, the lipid modification may con-
tribute to the tight association with the Golgi membrane in
combination with protein interactions. It is interesting to
note that a number of other Golgi proteins are palmitoy-
lated such as the glutamic acid decarboxylase isoform,
GAD65 (Solimena et al., 1994; Dirkx et al., 1995), and
eNOS (Sessa et al., 1995; Liu et al., 1997) but palmitoylation
is not required for the Golgi association. Interestingly,
eNOS cycles between surface caveolae and the Golgi com-
plex and shows a functional interaction with caveolin
(Michel et al., 1997; Feron et al., 1998). Palmitoylation has
been implicated in the lateral segregation of membrane as-
sociated proteins into DIGs (see Introduction) but, unlike
the full-length caveolins, Cav3KSY is detergent soluble (re-
sults not shown). As detergent insolubility is acquired in the
late Golgi/TGN (Scheiffele et al., 1998) this is consistent
with the proposed cis-Golgi location.
As well as protein interactions it is possible that the
Golgi association of Cav3KSY relies on specific lipid inter-
actions. Recently it was demonstrated that the cytoplasmic
oxysterol-binding protein, which associates with the Golgi
complex in response to oxysterols, is targeted specifically
to this compartment through interactions with a phos-
phatidylinositol polyphosphate plus some other Golgi de-
terminant (Levine and Munro, 1998). The COOH-ter-
minal Golgi targeted fragment of caveolin is relatively
hydrophobic and secondary structure predictions show a
possible helical conformation but it appears unlikely that
this domain can insert into the Golgi membrane. Previous
studies have shown that a fusion protein containing the
COOH terminus of cav-1 does not associate with mem-
branes after synthesis in vitro (Monier et al., 1995). This
domain of cav-1 is also accessible in vivo as COOH-termi-
nal antibodies specifically recognize the Golgi caveolin in
non-detergent permeabilized cells (Dupree et al., 1993). It
has also been shown to interact in vitro with signaling mol-
ecules such as n-NOS and c-src (Venema et al., 1997).
Whatever the molecular mechanism, our experiments show
a striking specificity of this domain for the Golgi complex
and should provide powerful tools for further analysis of
the molecular basis of Golgi localization. In addition, the
KSY and DGV mutants described here have functional ef-
fects on caveolae-mediated events including infection by
Simian Virus 40 and Ras signaling (Roy et al., 1999). Inter-
estingly, the present study showed that expression of the
COOH-terminal mutant caused a striking loss of detect-
able caveolin in the Golgi region but only in some cells in
the population. This effect was not correlated with expres-
sion levels and so the reason for the apparent cell-cell vari-
ation is unclear. One possibility is a difference in caveolin
cycling in cells at different stages of the cell cycle.
The data presented here provide important new in-
sights into the localization and targeting of this important
class of proteins which should be taken into account in fu-
ture models of caveolin function. Mutational dissection of
the caveolin molecule appears to be a particularly power-
ful approach to gain insights into the function and dynam-
ics of caveolin proteins and more detailed mutational
studies should provide further clues into the complex and
dynamic machinery comprising the caveolae membrane
system.
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